Labcorp launches new test for neurodegenerative disease and neuronal injury


Labcorp, the Burlington-based global life sciences company, has launched the first widely accessible test for neurodegenerative diseases and neuronal injury. The Neurofilament Light Chain (NfL) test is performed on a standard blood collection.

Previous Mike Tyson's cannabis company expands sales into Maryland
Next Inno Fire: UpStream Care growing rapidly, aiming for 1,000 employees, 1,200 physician partners